<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02608554</url>
  </required_header>
  <id_info>
    <org_study_id>Taichi for PCOS</org_study_id>
    <nct_id>NCT02608554</nct_id>
  </id_info>
  <brief_title>Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)</brief_title>
  <official_title>Taichi for Treating Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heilongjiang University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heilongjiang University of Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is a randomized pilot study, overweight/obese adolescent and young PCOS
      subjects will be assigned into two groups: Taichi arm and control arm. Hormonal profile and
      metabolic profile will be determined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body mass index (BMI)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral glucose tolerance test (OGTT)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Testosterone (T)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Luteinizing hormone (LH)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follicle stimulating hormone (FSH)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist/hip ratio</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferriman-Gallwey score</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Taichi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The 24 forms of simplified TCC recommended as the popular health sport by the General Administration of Sport of China were applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Self-monitored exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Taichi</intervention_name>
    <description>The program of Taichi training consisted of 60 minutes exercise sessions, 3 days per week for 12 weeks, based on their original level of physical activity. Each session comprised 40 minutes of Taichi training plus a 10-minute warm-up and cool-down. The Taichi training was instructed by the same experienced Taichi instructors who were qualified in the teaching of Taichi. The 24 forms of simplified Taichi recommended as the popular health sport by the General Administration of Sport of China were applied.</description>
    <arm_group_label>Taichi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-monitored exercise</intervention_name>
    <description>Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise for 60 mins. 3 days per week for 12 weeks.</description>
    <arm_group_label>Self-monitored exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged between 19 and 35 years;

          -  Diagnosis of PCOS according to the modified Rotterdam criteria;

          -  2 years after menarche;

          -  Body mass index (BMI) equal to or greater than 23 kg/m*m.

        Exclusion Criteria:

          -  Administration of other medications known to affect reproductive function or
             metabolism within the past three months, including oral contraceptives,
             Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens,
             gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such
             as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel
             blockers.

          -  Patients with other endocrine disorder including 21-hydroxylase deficiency,
             hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.

          -  Patients with known severe organ dysfunction or mental illness.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lihui Hou, Bachelor</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital of Heilongjiang University Of Chinese</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Li, Doctor</last_name>
    <phone>+86-451-82111401</phone>
    <email>liyantcm@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Affiliated Hospital, Heilongjiang University of Chinese Medicine</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lihui Hou, Bachelor</last_name>
      <phone>86-451-82111401</phone>
      <email>houlihui2007@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heilongjiang University of Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Yan Li</investigator_full_name>
    <investigator_title>Associate seiner physician</investigator_title>
  </responsible_party>
  <keyword>Polycystic ovary sybdrome</keyword>
  <keyword>Taichi</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

